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Abstract
Background: HSP70 plays crucial roles in endothelial cell apoptosis, which is involved in the early phase and progress of
coronary heart disease (CHD). However, the association between polymorphisms of HSP70 genes and the risk of CHD still
remains unclear. Our aim was to determine whether genetic variants in the HSPA1A gene are associated with the risk of
CHD.
Methodology/Principal Findings: By resequencing and genotyping, the associations of 2 single nucleotide polymorphisms
(SNPs) +190G/C (rs1043618) and 2110A/C (rs1008438) in the HSPA1A gene with risk of CHD were determined in a 1,003
pairs case-control study. The SNP function was further analyzed using a luciferase reporter assay in two cell lines. The results
indicated that +190CC genotype was associated with significantly higher risk of CHD when compared with +190GG
genotype (OR=1.56, 95% CI: 1.10–2.20, P=0.012), while association between 2110A/C polymorphism and CHD was not
statistically significant (P.0.05). However, the 2110C/+190C haplotype had a significantly higher risk of CHD when
compared with the 2110A/+190G haplotype (OR=1.17, 95% CI: 1.01–1.34, P=0.031). Luciferase reporter assays showed
that the +190C allele resulted in 14%,45% reduction in luciferase expression in endothelial and non-endothelial cells when
compared with the +190G allele.
Conclusions/Significance: The identified genetic variants in the HSPA1A gene combinatorially contribute towards the
susceptibility to CHD likely by affecting the level of synthesis of HSP70. This study may provide useful markers for
identification of subjects at risk for CHD.
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Introduction
Coronary heart disease (CHD) is one of the leading causes of
morbidity and mortality in China[1]. Each year there are about 2
million deaths from stroke- and CHD-related causes [2]. Gaining
insights into the pathogenesis of CHD and identification of
subjects at risk for CHD remains a tremendous challenge. It is well
established that endothelial cells are the first protective barrier of
vessel walls against various endogenous and exogenous stressors,
and they also play crucial roles in controlling vascular tone,
permeability, blood flow, coagulation, thrombolysis, inflammation
and tissue repair[3]. Damage or apoptosis of endothelial cells is
often considered as the initiating event of atherogenesis and also
accelerates endothelialized plaque erosion and thrombosis[4],
which will promote the development of acute cardiovascular
incidents of CHD, such as unstable angina and myocardial
infarction[5].
HSP70, as the main molecular chaperone, plays important roles
in protecting against a wide variety of stress stimuli, including
heavy metals, inflammation, and oxidative/ischemic injury[6].
Numerous evidences have corroborated the anti-oxidant and anti-
apoptosis roles of HSP70[7–11]. HSP70 has also been found in the
central portion of human atherosclerotic plaques[12]. Endothelial
cells subjected to various stress conditions express increased
amounts of HSP70 protein, which then functions as an antioxi-
dant[8] and inhibits key processes of apoptosis pathways, to
protect the integrity and functional activity of endothelial cells[13].
In addition, both in vivo and in vitro studies, indicated that the
increased expression of HSP70 can protect the heart from stressful
injury[14–17] and was associated with a reduction in myocardial
PLoS ONE | www.plosone.org 1 March 2009 | Volume 4 | Issue 3 | e4851apoptosis in ischemia-reperfusion injury[18]. It has been reported
that the SNPs and haplotypes of HSP70 may contribute to certain
disease susceptibility and stress tolerance [19–25]. HSPA1A is the
key component of the 12 members of the HSP70 family being
expressed both under normal conditions and substantively
stimulated after different stresses[26,27]. Based on the important
role of HSP70 in protecting the integrity and functional activity of
endothelial cells and its anti-oxidant properties, we hypothesized
that genetic variations in the HSPA1A gene might affect HSP70
protein expression, thus conferring one’s predisposition to CHD.
To comprehensively evaluate the potential implications of 2
single nucleotide polymorphisms (SNPs) of HSPA1A gene
(2110A/C and +190G/C polymorphisms) in the etiology of
CHD, we conducted a large-scale case-control study of 1,003
CHD cases and 1,003 age- and sex- frequency matched controls in
a Chinese population. Using an in vivo reporter assay in endothelial
cells (HUVEC) and non-endothelial cells (Hela), we found that the
SNP +190G/C (dbSNP accession number rs1043618), located in
the 59 untranslated region (UTR) of HSPA1A gene, may affect the
synthesis level of Hsp70 protein through translation efficiency or
post-transcriptional regulation.
Results
SNPs Identification in the 59 Flanking Region of HSPA1A
Gene in Han Chinese
Resequencing of the HSPA1A gene in 60 unrelated Han
Chinese revealed two SNPs in 59 flanking region of HSPA1A
gene. Referring the gene transcription start site as +1, one SNP is
2110A/C (dbSNP accession number rs1008438) in the core
promoter region and the other is +190G/C in the 59UTR region,
with minor allele frequency of 0.355 and 0.240 respectively. There
were significant differences in allele frequencies of 2110A/C and
+190G/C across different ethnic groups (P,0.05) (Table 1).
General Characteristics of the Subjects
The clinical and demographic features of subjects have been
described in our previous study[28]. In summary, CHD patients
had a higher prevalence of conventional vascular risk factors,
including smoking, non-drinking, history of hypertension and DM,
family history of CHD and higher level of FBG, whereas TC level
in patients were lower in cases than controls, probably due to
cholesterol-lowering treatment in the cases.
HSPA1A Genotypes and CHD Risk
These two bi-allelic SNPs were investigated in 1,003 CHD
patients and in controls. The distributions of SNPs +190G/C and
2110A/C did not depart from the Hardy-Weinberg equilibrium
in the control group (P=0.18 and 0.32 respectively). Genotype
frequencies of the two studied SNPs are summarized in Table 2.
There was borderline significant difference in genotype distribu-
tions of SNP +190G/C between CHD cases and controls, but
adjustment for the conventional risk factors such as age, sex, pack-
year of smoking, drinking, activity, hypertension, DM, and family
history of CHD yielded significant results (P=0.012). Compared
with GG genotype of +190G/C, subjects with CC genotype had a
higher risk of CHD after adjusting for the conventional risk factors
above (Crude OR=1.33, 95% CI: 1.00–1.77, P=0.052 and
adjusted OR=1.56, 95% CI: 1.10–2.20, P=0.012 respectively).
There was no significant difference between CHD cases and
control group in 2110A/C locus before or after adjusting for
conventional risk factors (P.0.05). Haplotype analysis indicated
that patients with 2110C/+190C haplotype had a higher risk of
CHD when compared with 2110A/+190G haplotype
(OR=1.17, 95% CI: 1.01–1.34, P=0.031) (Table 3).
HSPA1A 59 Flanking Region Carrying the +190C
Polymorphisms leads to Lower HSP70 Expression
To investigate the possible functional significance of the SNPs in
the HSPA1A gene, plasmids were constructed with luciferase as
reporter gene and transfected in cultured cells. Under normal
culture status, the RLA of all constructs containing fragments that
include both core promoter region and 59UTR of HSPA1A gene
(2513 to +216) were remarkably higher than those carrying only
the core promoter region (2513 to 21) in Hela, and HUVEC cells
(P,0.0001) (Figure 1b). As for the four distinct haplotype
plasmids, the RLA of 2110A/+190G and 2110C/+190G
haplotype were significantly higher than that of 2110A/+190C
and 2110C/+190C respectively (P,0.001), but no differences
were found between 2110A/+190G and 2110C/+190G haplo-
type nor between 2110A/+190C and 2110C/+190C haplotype,
suggesting that the reduction of RLA was due to the presence of
the +190C allele (Figure 1b). To further explore the regulatory
properties of the SNPs, transfected cells were submitted to a heat
shock. The RLA recorded, were increased for about 6,7 times in
Hela cells and about 20 times in HUVEC cells. In the heat shock
groups, the results were similar to those under normal conditions
in all cells (Figure 1c). The HSPA1A 59-flanking region bearing the
2110C/+190C haplotype exhibited about 30%,50% lower RLA
than the 2110A /+190G haplotype in endothelial (HUVEC) and
non-endothelial cells (Hela). We also inserted the full-length
59UTR containing either +190G or +190C directly following the
SV40 promoter and before the translation start codon of the firefly
luciferase gene of pGL3-Control vector (Figure 2a). The full-length
59UTR of HSPA1A gene increased luciferase activity of the pGL3-
Control vector (P,0.001), with the +190C allele resulting in
14%,45% reduction in luciferase expression compared to the
+190G allele in Hela and HUVEC cell lines (P,0.001, and
P=0.007, respectively) (Figure 2b).
Discussion
Our study is among the few that examined the association
between SNPs of HSPA1A gene and risk of CHD. Resequencing of
this gene in 60 unrelated Han Chinese revealed two SNPs in 59
Table 1. Comparison of Allele Frequencies of Polymorphisms
in HSPA1A genes among Different Populations [36].
SNPs Population Wild type
Mutation
type P Value
HSPA1A 2110A/C A C 0.000
Han Chinese 0.645 0.355
Sub-Saharan African 0.083 0.917
Hispanic 0.477 0.523
European 0.886 0.114
HSPA1A +190G/C G C 0.001
Han Chinese 0.760 0.240
Japanese 0.802 0.198
CEU* 0.658 0.342
Yoruba 0.902 0.098
*CEU: Utah residents with ancestry from northern and western Europe.
doi:10.1371/journal.pone.0004851.t001
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promoter and the other is +190G/C located in the 59UTR region.
The allele frequencies of these two SNPs in the Han Chinese
population were significantly different from Sub-Saharan African,
Hispanic and European races. Our large case-control analysis
showed no strong association between 2110A/C polymorphism
and CHD, which was consistent with the result of a previous
European study that indicated no association between this
polymorphism and myocardial infarction[28]. However, we found
that the +190C allele and the haplotypes containing +190C were
significantly associated with CHD risk. Since the two SNPs both
reside in the highly conserved regulatory region of the gene, we
further explored their putative effects on HSPA1A promoter
activity and found that the HSPA1A 59UTR enhanced expression
of a luciferase reporter driven either by the HSPA1A or SV40
promoter; the allele-specific data of reporter assays in both
endothelial (HUVEC) and non-endothelial (Hela) cells yielded
consistent results that the +190C allele in the 59UTR of HSPA1A
gene leads to a reduction in promoter activity and probably lower
synthesis level of HSP70 protein than +190G allele.
The function of HSPA1A 59UTR sequence of HSPA1A mRNA
was comprehensively analyzed and reported to act as a general
enhancer of mRNA translation[29]. Our findings are consistent
with the above study and the effect of HSPA1A 59UTR was
independent of the promoter used. The HSPA1A 59UTR sequence
has an internal ribosome entry site (IRES) for translation initiation
by a cap-dependent mechanism, which depends on its 3-
dimensional secondary structures of full-length 59UTR, especially
the base-pairing status and nucleotide context of the 39-terminal
AUG-proximal region of HSPA1A 59UTR [30]. Theoretical
secondary structure folding analysis by Mfold program suggested
that the HSPA1A 59UTR sequence containing +190G or +190C
allele had distinct thermodynamic parameters and different stem-
loop structure in its 39-terminal region[31]. Albeit untested
experimentally, the modulation caused by the +190 G/C
polymorphism, which is just 26 bp upstream the initial codon,
may arise from altered stem-loop structure of the 59UTR of
HSPA1A mRNA, thus confer different efficiency of HSPA1A
mRNA translation. Since heat shock treatment is the typical model
up-regulating expression of HSP70, we can postulate that such
difference in 59UTR may also be applicable under other stresses,
such as inflammation, ischemic and oxidative injury, all of which
play critical roles in the pathogenesis of CHD.
Thus we showed that the 2110C/+190C haplotype, which was
significantly associated with CHD risk had a 30%,50% lower
RLA than 2110A /+190G haplotype in both endothelial and
non-endothelial cells. The RLA of HSPA1A promoter plasmid
driven by 2110A was higher than that of 2110C in Hela cell
lines, but didn’t reach the significant level in HUVEC cells (data
not shown). We would like to speculate that the 2110A/C
polymorphism is also a potential functional SNP, and that when
combined with +190G/C polymorphism, may act as an additive
effect on the synthesis of HSP70 protein.
The present study has several strengths. First, our population
was highly homogenous with respect to ethnicity and geographic
regions, which minimizes the possible biases related to population
stratification. In addition, the large number of cases and controls
provided sufficient power to detect moderate effects of the
genotypes and haplotypes. Finally, the possible patho-physiological
significance of the +190G/C polymorphism was further confirmed
by detailed functional assays in both endothelial and non-
endothelial cell lines with consistent results. This strengthened
Table 3. Haplotype Distribution of HSPA1A in CHD and
Control Group.
Haplotype
(2110/+190) CHD Controls OR (95% CI)
n%n%
2110A/+190G 1092 54.44 1118 55.74 1.00
2110C/+190C 657 32.75 577 28.76 1.17 (1.01–1.34)*
2110C/+190G 208 10.37 256 12.76 0.83 (0.68–1.02)
2110A/+190C 49 2.44 55 2.74 0.91 (0.62–1.35)
Total 2006 100 2006 100 —
Polymorphic bases were in 59 to 39 order and from left to right the order is
2110A/C and +190G/C.
*Compared with 2110A/+190G haplotype, P=0.031.
doi:10.1371/journal.pone.0004851.t003
Table 2. Analysis of Association between HSPA1A Polymorphisms and Risk of CHD in a Chinese population.
Genotype Cases Controls
Crude OR
(95% CI)
Adjusted OR
(95% CI)*
n% n %
+190G/C
GG 434 44.2 479 47.8 1.00 1.00
GC 416 42.4 415 41.4 1.11(0.92–1.34) 1.04(0.83–1.31)
CC 131 13.4 109 10.8 1.33(1.00–1.77)
{ 1.56(1.10–2.20)
{
GC+CC 547 55.8 524 52.2 1.15(0.97–1.38) 1.13(0.91–1.40)
2110A/C
AA 317 32.3 350 34.9 1.00 1.00
AC 476 48.6 472 47.1 1.11(0.91–1.36) 1.15(0.90–1.46)
CC 187 19.1 181 18.0 1.14(0.88–1.47) 1.17(0.86–1.60)
AC+CC 663 67.7 653 65.1 1.12(0.93–1.35) 1.14(0.91–1.43)
*Adjusted for age, sex, pack-year of smoking, drinking, activity, hypertension, DM and family history of CHD. Compared with GG genotype.
{P=0.052 and
{P=0.012, respectively.
doi:10.1371/journal.pone.0004851.t002
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CHD revealed by the present study. However two limitations
should also be acknowledged. First, because this was a retrospec-
tive study, a possible selection bias (inclusion of patients surviving
CHD) and/or systemic error may exist. However, there was no
evidence that these SNPs influence survival. Meanwhile, we
selected controls that had normal electrocardiograms and no
history and signs of CHD, but we can not exclude the possibility
that some of them were affected by silent myocardial infarction
because we did not perform coronary angiography on those
control subjects. However, the prevalence of CHD in China is still
low[32], especially among those without positive ECG test or
clinical symptoms. All our controls were required to have normal
ECG and no clinical symptoms before enrollment, thus the false
negative cases in the controls are likely to be rare.
In conclusion, our results of the large-scale case-control study
and reporter assays support the hypothesis that reduced expression
of HSP70 protein induced by the HSPA1A +190C allele may
dampens its cytoprotection role on endothelial cells and thus
contributes to one’s predisposition to CHD. Our study provides
the first evidence that genetic variants in HSPA1A gene may
potentially contribute to the susceptibility to CHD. However, our
findings need to be replicated in additional studies, especially in
large prospective cohort studies.
Materials and Methods
Human Subjects and General Characteristics
The study design for this investigation has been described
elsewhere[33]. Briefly, the study population was composed of
1,003 cases and 1,003 age- and sex- frequency matched controls.
All enrolled subjects were unrelated ethnic Han Chinese. Case
Figure 2. Effect of +190G/C polymorphism on the expression of
luciferase. (a), Schematic representation of reporter constructs. (b),
These constructs and empty pGL3-Control plasmid were transfected
into Hela and HUVEC cells. All constructs were cotransfected with pRL-
SV40 to standardize the transfection efficiency. RLA was determined
24 hours later in normal culture condition. The RLA values are
presented as means, and the T bars represent standard deviations
(SD). Mean6SD from triplicates.
doi:10.1371/journal.pone.0004851.g002
Figure 1. Effects of 2110A/C and +190G/C polymorphisms on
luciferase activity. (a), Schematic representation of HSPA1A gene 59
flanking region and reporter constructs. (b) to (c), the six reporter
constructs and empty pGL3-Basic was transfected into Hela and HUVEC
cells under normal culture (b) or heat shocked conditions (c). All
constructs were cotransfected with pRL-SV40 to standardize the
transfection efficiency. Fold increase of luciferase activity was measured
by defining the activity of the empty pGL3-Basic vector as 1. The RLA
values are presented as means, and the T bars represent standard
deviations (SD). Mean6SD from triplicates.
doi:10.1371/journal.pone.0004851.g001
HSPA1A and Heart Disease
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Union Hospital, and Wugang Hospital) in Wuhan City, Hubei
province, were diagnosed as having CHD according to WHO
criteria or by coronary angiography (significant coronary artery
stenoses $50% in at least one major coronary artery). A total of
1,078 patients diagnosed as having CHD were recruited; 1,003 of
them (93.0%) consented to participate in the study and provided
questionnaire information and blood samples. The control
subjects, residing in the same communities as the cases, were
judged to be free of CHD and peripheral atherosclerotic arterial
disease by medical history, clinical examinations, and electrocar-
diography (ECG). The response rate for the controls was 92.4%
(1,003 of 1,085). Subjects with severe liver and/or kidney disease
were excluded. Subjects were classified as nonsmokers, former, or
current smokers. Pack-years were calculated by multiplying the
number of packs of cigarettes smoked per day by the number of
years the person had smoked. BMI was calculated as weight in
kilograms divided by the square of height in meters. Subjects were
considered to be hypertensive if their systolic blood pressure was
$140 mmHg and/or diastolic pressure $90 mmHg or they were
already being treated with antihypertensive drugs. Medical history,
socio-demographic information, family history of cardiovascular
disease, medication use, home environment, and lifestyle
factors were obtained through questionnaire interview. All subjects
gave written consent after receiving a full explanation of the study.
The Ethics Committee of Tongji Medical College approved the
study.
Screening for SNPs in 59 Flanking Region of HSPA1A Gene
in Chinese
DNA samples extracted from whole blood of 60 randomly
selected healthy subjects were used to identify SNPs in the 59
flanking region of HSPA1A gene (GenBank accession
no. NM_005345) in the Han Chinese population. Sequencing
reactions were carried out on an ABI 3100 genetic analyzer. All
primers and reaction conditions are listed in Table S1.
Genotyping of HSPA1A polymorphisms
Genotyping of HSPA1A was performed with 59 nuclease
TaqMan allelic discrimination assay on an ABI 7900HT real-
time quantitative PCR system (Applied Biosystems), in 384-well
format. For 2110A/C polymorphism, the TaqMan primers were
59- GCCTCTGATTGGTCCAAGGAA-39 and 59-GCTGCCA-
GGTCGGGAATAT-39,while probes were FAM - AGGCGAAA-
CCCCTGG-MGB for 2110C and VIC- AGGCGAAAACCC-
TGG –MGB for 2110A. The catalog number for +190G/C
polymorphism was C-11917510-10. Finally, genotyping failed in
22 (2.20%) cases in +190G/C locus, 23 (2.30%) cases in 2110A/
C locus owing to DNA quantity or quality.
Biological variables determination
Fasting blood glucose (FBG), total cholesterol (TC), and
triglyceride (TG) were assayed using standard laboratory proce-
dures at the Department of Clinical Laboratory at the Wuhan
Union Hospital.
Construction of Reporter Plasmids
We constructed six reporter plasmids based on pGL3-Basic
vector (Promega, Madison, Wisconsin, USA), including four
fragments compassing from 2513 to +216 according to their
haplotypes (2110A/+190G, 2110A/+190C, 2110C/+190G and
2110C/+190C, respectively) and two core promoter regions from
2513 to 21 containing either 2110A or 2110C allele. The
position ‘‘+1’’ indicates the transcription start site (Figure 1a).
They were all inserted into Kpn I/Hind III enzyme sites of pGL3-
Basic. We also inserted the full-length 59UTR containing +190G
or +190C allele into the Hind III /Nco I enzyme sites of pGL3-
Control vector. Primer pairs designed for plasmid constructs and
site-specific mutagenesis are listed in Table S2. The direction and
sequence authenticity of the above constructs were validated by
restriction analysis and direct sequencing.
Transient Transfection and Luciferase Reporter Assays
Hela cells were cultured with RPMI 1640 containing 10% fetal
bovine serum and seeded into 96-well plates at a density of 3610
4
cells per well respectively, while 4610
4 human umbilical vein
endothelial cells (HUVEC) were seeded into 48-well plates.
Twenty-four hours later when cells had grown to about 70%
confluence, each well was co-transfected with 100 ng pGL3-Basic
plasmids or its constructs (defined as 2110A, 2110A/+190G,
2110A/+190C, 2110C, 2110C/+190G, 2110C/+190C) and
1 ng pRL-SV40 (Promega) using Lipofectamine 2000 (Invitrogen,
Carlsbad, California, USA) according to the manufacturer’s
protocol. The Hela and HUVEC cells were harvested 24 hours
after transfection, whereas in the heat-shocked group, cells were
placed at 42uC for 1 hour in a water bath and then allowed to
recover at 37uC for 4 hours before measurement. Then luciferase
activity was measured using Dual-Luciferase Reporter Assay
System (Promega) on a TD-20/20
n luminometer (Turner Design,
Promega). Each construct was tested in six assays and the
transfection experiments were performed three times indepen-
dently. As for the pGL3-Control and its constructs, the same
transfection procedures were done. The result was denoted as
relative luciferase activity (RLA) since the luciferase activity was
normalized by Renilla activity and the empty pGL3-Basic or
pGL3-Control vector.
Statistical Analysis
Normal distribution of data was checked by the Komogorov-
Smirnov normality test. Data with a normal distribution were
compared by Student’s t-test, and those with unequal variance or
without a normal distribution were analyzed by a nonparametric
Mann-Whitney rank sum test. Different RLA of four haplotypes
contained plasmids were determined by one-way ANOVA and
Student-Newman-Keuls test. A Chi-square test was applied to
compare categorical variables and the Hardy-Weinberg equilib-
rium of the polymorphisms. The linkage relationship between the
two SNPs in HSPA1A genes was measured by linkage disequilib-
rium analyzer (LDA) program[34]. All genotype data for each
sample were taken to infer the haplotypes by using the PHASE 2.0
program[35], a software for reconstruction of haplotypes from
population genotype data by Bayesian statistical method. The
associations between variants and CHD risk were estimated by
odds ratios (ORs) and 95% confidence intervals (CIs) by using the
unconditional logistic regression analyses with adjustment for
multiple cardiovascular risk factors such as age, sex, pack-year of
smoking, drinking activity, hypertension, diabetes mellitus (DM),
and family history of CHD. A P value of less than 0.05 was
considered significant. All data analyses were carried out with
statistical analysis software package SPSS 12.0 (SPSS Inc.,
Chicago, Illinois, USA).
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0004851.s001 (0.04 MB
DOC)
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